Mercer Global Advisors
RGNX icon

Mercer Global Advisors’s Regenxbio RGNX Stock Holding History

Mercer Global Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
31,444
+7,604
+32% +$63.1K ﹤0.01% 2572
2026
Q1 		$200K Sell
23,840
-300
-1% -$3.15K ﹤0.01% 2837
2025
Q4 		$348K Buy
24,140
+4,224
+21% +$52.6K ﹤0.01% 2116
2025
Q3 		$192K Buy
+19,916
New +$176K ﹤0.01% 2400
2023
Q1 		– Sell
-13,761
Closed -$312K – 2029
2022
Q4 		$312K Buy
13,761
+2,183
+19% +$49.4K ﹤0.01% 1482
2022
Q3 		$306K Buy
+11,578
New +$343K ﹤0.01% 1393

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Mercer Global Advisors's RGNX Position: Q2 2026 in Review

Mercer Global Advisors increased its Regenxbio (RGNX) stake by 32% in Q2 2026, buying an estimated $63.1K and bringing the position to 31,444 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Mercer Global Advisors first reported a position in RGNX in Q3 2022 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Mercer Global Advisors held 31,444 shares of Regenxbio worth $377K as of Q2 2026.
  • Mercer Global Advisors bought 7,604 Regenxbio shares in Q2 2026, an estimated $63.1K.
  • Regenxbio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2572 holding.
  • Mercer Global Advisors first reported a position in Regenxbio in Q3 2022 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.